1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas

Pravesh Gupta; Minghao Dang; Dapeng Hao; Krishna Bojja; Tuan Tran; Huma Shehwana; Carlos Kamiya-Matsuoka; Jianzhuo Li; Alessandra Audia; Cynthia Kassab; Martina Ott; Joy Gumin; Sanaalarab Alenazy; Alicia Goldman; Sameer Seth; Atul Maheshwari; Veerakumar Balasubramaniyan; Brian Vaillant; John de Groot; Antonio Lavarone; Frederick Lang; Nicholas Navin; Amy Heimberger; Linghua Wang; Krishna Bhat

doi:10.1136/jitc-2022-SITC2022.1001

Article info

PDF

Regular and Young Investigator Award Abstracts

Immune Cell Types and Biology

1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas

Free

Authors

Pravesh Gupta University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Minghao Dang University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Dapeng Hao University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Krishna Bojja University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Tuan Tran University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Huma Shehwana University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Carlos Kamiya-Matsuoka University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Jianzhuo Li University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Alessandra Audia University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Cynthia Kassab University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Martina Ott University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Joy Gumin University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Sanaalarab Alenazy University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Alicia Goldman Baylor College of Medicine, Houston, TX, United States PubMed articles Google scholar articles
Sameer Seth Baylor College of Medicine, Houston, TX, United States PubMed articles Google scholar articles
Atul Maheshwari Baylor College of Medicine, Houston, TX, United States PubMed articles Google scholar articles
Veerakumar Balasubramaniyan University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Brian Vaillant The University of Austin, Austin, TX, United States PubMed articles Google scholar articles
John de Groot University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Antonio Lavarone Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, United States PubMed articles Google scholar articles
Frederick Lang University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Nicholas Navin University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Amy Heimberger Feinberg School of Medicine, Northwestern University, Chicago, IL, United States PubMed articles Google scholar articles
Linghua Wang University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles
Krishna Bhat University of Texas MD Anderson Cancer Center, Houston, TX, United States PubMed articles Google scholar articles

Citation

Gupta P, Dang M, Hao D, et al

1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas

Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.1001

Publication history

First published November 7, 2022.

Online issue publication

April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password